Board Meeting Intimation for Under Regulation 29 Of SEBI Listing Obligation And Disclosure Requirements 2015 For Holding Board Meeting For Approval Of Un-Audited Financial Results For The Quarter Ended June 30 2026
08-Aug-2026 | Source : BSENorris Medicines Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve Unaudited Financial Results for the Quarter Ended 30th June 2026
Board Meeting Outcome for Outcome Of The Board Meeting Dated 30Th July 2026.
30-Jul-2026 | Source : BSEOutcome of Board Meeting held on Thursday July 30 2026 pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.
Announcement under Regulation 30 (LODR)-Change in Management
30-Jul-2026 | Source : BSEIntimation relating to appointment of Mr. Iqubal Ismail Patel as Chief Financial Officer (CFO) & Key Managerial Personnel (KMP) of the Company in the meeting of the Board dated 30th July 2026.
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available